{"database": "lobbying", "table": "lobbying_activities", "rows": [[2148556, "52f22542-dd19-47f9-a33b-74034852d9f5", "Q2", "THE D MAJOR GROUP", 401103162, "ALLERGAN INC (FORMERLY ACTAVIS INC )", 2018, "second_quarter", "CPT", "Advocate for Inter Partes Review (IPR) reform concerning pharmaceuticals.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2018-07-17T19:28:41.700000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2148556"], "units": {}, "query_ms": 20.667913020588458, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}